Generic Drug News and Research

RSS

Generic Drugs are official nonbrand names by which medicines are known. Generic names usually refer to the chemical name of the drug.

Spending on prescription drugs dropped slightly in 2012

The decrease was miniscule, but it was the first time since 1957 that the research firm IMS Health had recorded a dip in United States drug expenditures, reports The New York Times. In related news, more effective use of medications could lead to Medicare savings, according to the Congressional Budget Office.

20 Mar 2013

Generic drugmaker liability question to be argued Tuesday before the High Court

The Supreme Court will hear arguments on Tuesday in a case that could decide whether generic drugmakers can be held liable for alleged flaws in the designs of their medications, even though federal law requires generic manufacturers to copy the brand drugmaker's design.

19 Mar 2013

Supreme Court slated to hear legal arguments regarding generic drug liability question

Generic drugs are supposed to be identical to the brand names that preceded them. And by law, they have to have identical warnings and labels.

16 Mar 2013

First Edition: March 15, 2013

Today's headlines include reports about President Barack Obama's third day of Capitol Hill visits in pursuit of progress on the budget.

15 Mar 2013

Synthesis & Solid State Pharmaceutical Centre: an interview with Dr Mary Shire, University of Limerick

This is a new research centre led by the University of Limerick that supports the pharmaceutical sector in Ireland. The centre will carry out research on the key aspects of what it takes to synthesise the pharmaceutically active molecule to isolate a pure material and to formulate this into a medicine.

14 Mar 2013

Brand-name and generic drug makers join forces to challenge FTC

Brand and generic drug companies are usually at each other' throats.

13 Mar 2013

Trans-Pacific Partnership (TPP) Agreement: an interview with Judit Rius, Médecins Sans Frontières

The Trans-Pacific Partnership (TPP) is a trade deal currently being negotiated between eleven countries of the Asia-Pacific region: Australia, Brunei Darussalam, Canada, Chile, Malaysia, Mexico, New Zealand, Peru, United States, Singapore and Vietnam.

12 Mar 2013

First Edition: March 12, 2013

Today's headlines include reports about this week's roll out of budgets on Capitol Hill and how Democratic and Republican fiscal blueprints will underscore key partisan differences.

12 Mar 2013

Viewpoints: 5 lies about entitlements; Obama's plans for Medicare still not clear; Generic drug makers need to be accountable

So here's a list with a bit more gravitas: The five biggest lies you're being told about entitlement programs. Never mind that the very word "entitlement" is a lie. Social Security and Medicare got that name because workers became "entitled" to those benefits by paying into the system. In recent years, however, the term has become distorted to signify benefits people are entitled to without earning them. Leaving that whopper aside, here are the top five.

12 Mar 2013

High Court to consider whether drug company deals restrain trade

Generic drugs have dramatically changed the pharmaceutical and health-care landscape in the last 25 years and now account for about 80 percent of prescriptions in the United States, with lower prices for consumers and insurers.

7 Mar 2013

Médecins Sans Frontières’ concerns over TPP negotiations

As closed-door talks for the Trans-Pacific Partnership (TPP) Agreement resume in Singapore this week, international medical humanitarian organisation Médecins Sans Frontières is calling on Australia and negotiating countries to reject rules that threaten to dismantle internationally agreed public health safeguards and restrict access to medicines in developing countries.

4 Mar 2013

Research roundup: Patients hesitant to focus on costs; Increase in primary care demand is uneven

One way to contain health care spending is to get patients involved in weighing costs of treatment options with their doctors. Researchers recruited 211 medically insured participants to assess their willingness to consider costs when choosing treatments. The authors found that participants generally "preferred better care, even when the relative benefit it offered was marginal, and even when told that the second-best choice still met the threshold of 'good enough' care from a clinician's perspective.

26 Feb 2013

Comprehensive portfolio of antiretroviral products from Mylan

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary in South Africa, Mylan (Proprietary) Limited, has launched a comprehensive portfolio of antiretroviral (ARV) products.

25 Feb 2013

FDA approves Amneal’s generic Suboxone to treat opioid drug dependence

Amneal Pharmaceuticals, LLC, the 7th largest generic drug manufacturer in the U.S. market, has received U.S. FDA approval for one of the first generic versions of Suboxone sublingual tablets for maintenance treatment of opioid drug dependence.

25 Feb 2013

Policymakers, insurers should consider generic-only coverage to improve health and reduce costs

A new study published online today in the American Journal of Managed Care found that in Medicare Part D, generic drug coverage was cost-saving compared to no coverage in bipolar disorder and schizophrenia, while also improving health outcomes.

21 Feb 2013

FDA approves Teva’s generic Adderall XR ANDA for treatment of ADHD

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for the generic version of Shire's Adderall XR Capsules, 5mg, 10mg, 15mg, 20mg, 25mg and 30 mg capsules for the treatment of attention deficit hyperactivity disorder.

14 Feb 2013

Cantor calls for repeal of medical device tax; Bipartisan Senate bill seeks to end generic drug delays

In a speech, the House majority leader criticized the health law but focused his attention on the overhaul's taxes. Meanwhile, the Senate measure would prohibit companies that make brand-name drugs from paying generic manufacturers to keep their products off the market.

7 Feb 2013

Teva initiates enrollment in AZILECT Phase IV clinical study for PD-MCI

Teva Pharmaceutical Industries Ltd. announced today enrollment of the first patient in the MODERATO study - a Phase IV clinical study designed to evaluate the effect of AZILECT (rasagiline tablets) on cognitive function in adults with mild cognitive impairment (MCI) in Parkinson's disease (PD-MCI).

6 Feb 2013

Viewpoints: Congress must put entitlements on 'more sustainable path;' Reading, writing and mental health screenings

What's needed now is a clear, achievable plan to bring the debt and deficit under control for the long term. A crucial part of any such plan is promoting a more vigorous economy, possibly by simplifying the federal tax code. Another important piece is putting entitlements on a more sustainable path, reducing the drain on the Treasury. That means expanding on the 2010 healthcare law's efforts to increase efficiency, quality and innovation in healthcare.

1 Feb 2013

Teva terminates collaboration with CureTech

Teva Pharmaceutical Industries Ltd. announced today the termination of its collaboration with CureTech Ltd.

31 Jan 2013

Generic Drug News and Research

Further Reading

Spending on prescription drugs dropped slightly in 2012

Generic drugmaker liability question to be argued Tuesday before the High Court

Supreme Court slated to hear legal arguments regarding generic drug liability question

First Edition: March 15, 2013

Synthesis & Solid State Pharmaceutical Centre: an interview with Dr Mary Shire, University of Limerick

Brand-name and generic drug makers join forces to challenge FTC

Trans-Pacific Partnership (TPP) Agreement: an interview with Judit Rius, Médecins Sans Frontières

First Edition: March 12, 2013

Viewpoints: 5 lies about entitlements; Obama's plans for Medicare still not clear; Generic drug makers need to be accountable

High Court to consider whether drug company deals restrain trade

Médecins Sans Frontières’ concerns over TPP negotiations

Research roundup: Patients hesitant to focus on costs; Increase in primary care demand is uneven

Comprehensive portfolio of antiretroviral products from Mylan

FDA approves Amneal’s generic Suboxone to treat opioid drug dependence

Policymakers, insurers should consider generic-only coverage to improve health and reduce costs

FDA approves Teva’s generic Adderall XR ANDA for treatment of ADHD

Cantor calls for repeal of medical device tax; Bipartisan Senate bill seeks to end generic drug delays

Teva initiates enrollment in AZILECT Phase IV clinical study for PD-MCI

Viewpoints: Congress must put entitlements on 'more sustainable path;' Reading, writing and mental health screenings

Teva terminates collaboration with CureTech

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News